SCHEMBL26569550

SCHEMBL26569550

C=C[C@@](C)(NCC(=O)OC)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TET2 Q6N021 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
RECQL P46063 1/20 0.36
CA12 O43570 1/20 0.36
CA2 P00918 1/20 0.36
CA14 Q9ULX7 1/20 0.36
BIRC2 Q13490 1/20 0.34
EPHX2 P34913 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
TSHR P16473 5/20 0.32
HSD17B10 Q99714 3/20 0.31
KDM4E B2RXH2 2/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
GAA P10253 2/20 0.30
MGAM O43451 1/20 0.30
SI P14410 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19944903 0.75 TET2 (0.43) TET2ALDH1A1LMNARECQLCA12
SCHEMBL21129653 0.70 TET2 (0.46) TET2ALDH1A1LMNARECQLCA12
SCHEMBL757885 0.69 TET2 (0.50) TET2ALDH1A1LMNARECQLCA12
SCHEMBL4813094 0.69 TSHR (0.52) TET2ALDH1A1LMNARECQLCA12
SCHEMBL16299703 0.68 TET2 (0.45) TET2ALDH1A1LMNARECQLCA12
Hydrochloric Acid SCHEMBL344744 0.68 TET2 (0.48) TET2ALDH1A1LMNARECQLCA12
SCHEMBL3267023 0.67 TET2 (0.43) TET2ALDH1A1LMNARECQLCA12
SCHEMBL20081225 0.67 TSHR (0.32) ALDH1A1TSHR
SCHEMBL21781786 0.67 CA1 (0.40) CA12CA2CA14MEN1KMT2A
SCHEMBL11941662 0.67 CA14 (0.33) CA12CA14TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed